WHO WE ARE: INFUSION INNOVATIONS, INC. (I3)
Infusion Innovations, Inc. (I3) is a California Corporation, based in La Jolla, California. We are focused on the design, development, manufacturing, and commercialization of innovative products for improved safety of the hospital environment.
The fundamental driving philosophy behind all products is bringing key engineering innovation to improve safety, ease of use, and functionality of established hospital based products.
CLOSED SYSTEM TRANSFER DEVICE
Q-FLO, I3’s lead product, is a “Closed System Transfer Device”, (CSTD), a medical device for use in the compounding and administration of 200+ Hazardous Drugs (HD), protected by over 24 issued global patents. Q-FLO is FDA approved and CE marked, tested, and in use in hospitals and pharmacies. Q_FLO is highly price competitive with superior performance benefits over any other CSTD device. Q-FLO is in mass production with tooled for production.
Over 15 years of research and 150+ published papers have documented the health hazards and danger of handling toxic chemotherapy drugs by nurses and physicians. The mandated use of CSTD’s protects Healthcare workers. Few “standalone” male luer CSTD’s.
I3's lead CSTD product, Q-FLO is a standalone male luer device; USP compliant, 510K cleared with wide indications for use, low in cost, easy to use and train; universally compatible with all available female luer connectors.
Superior to other devices in usability, safety features, low priming volume ensuring safety across full spectrum of care, compounding, administration, and disposal of HD’s.
I3 HAS A WORLD CLASS TEAM WITH HIGHLY-RELEVANT EXPERIENCE
The leadership team includes over 150 years of combined experience in the industry with a focus on complementary industry backgrounds.
PETER SMITH, CEO
Has extensive experience as a Founder, CEO, and COO of a variety of global businesses. LLPG, NFL in Europe, and Cobra Golf Europe. Negotiated the first commercial license from Disney’s IP portfolio to create Luminara. An expert in business building and International licensing whilst delivering optimal shareholder value. “C-suite” roles during two IPO’s.
BABAK NEMATI, PH.D., FOUNDER, CHAIRMAN
Has 30+ years in the medical device industry at leading healthcare companies: Johnson & Johnson. Currently advisor to a number of venture capital, private equity, and strategic investors on new and emerging medical device technologies.
DAVID STROUP, FOUNDER, BOARDMEMBER
Inventor of the Q-FLO™ and Co-Founder of Infusion Innovations, with over 20 years of experience in the medical device industry. Founder of Pathway, LLC, a medical device development and manufacturing service provider based in San Diego. Former Founder and CEO of Prodosyst Automation, Inc., serving Fortune 500 companies in automated manufacturing.
GEORGE WALKER, BOARD MEMBER
Founder & CEO of Integra Biotechnical, LLC, a highly successful manufacturer of medical device products (acquired Providien 2011). Served over 40 companies, including market-leading medical device companies, and engineered thousands of successful products. Member of the Tech Coast Angels,